PharmaEssentia Initiates Phase 3b Trial of Ropeginterferon alfa-2b-njft Investigatng New Dosing Regimen for Patients With Polycythemia Vera (PV)

Press/Media

Period	3 May 2023

Media coverage

Title	PharmaEssentia Initiates Phase 3b Trial of Ropeginterferon alfa-2b-njft Investigatng New Dosing Regimen for Patients With Polycythemia Vera (PV)
Media name/outlet	South Africa - Knowledia News
Country/Territory	South Africa
Date	3/05/23
URL	https://news.knowledia.com/ZA/en/articles/pharmaessentia-initiates-phase-3b-trial-of-ropeginterferon-alfa-2b-njft-dd4db9a68ae8d3b9b1b05767d2edf8ec7abf94a9?source=rss
Persons	John Mascarenhas